Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel
LON:GENI

GENinCode 9/30/2025 Earnings Report

GENinCode logo
GBX 1.10 +0.05 (+4.76%)
As of 05:20 AM Eastern
ProfileEarnings History

GENinCode EPS Results

Actual EPS
-GBX 1.19
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GENinCode Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GENinCode Announcement Details

Quarter
Date
9/30/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GENinCode Earnings Headlines

GENinCode slumps after it reprices options
May 7, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-slumps-reprices-options-101000125.html
GENinCode (LON:GENI) Stock Price Down 0.9% - What's Next?
May 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30762953
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
May 15 at 1:00 AM  |  Profits Run (Ad)
AIM Market Roundup: Phoenix Copper, Pipehawk, Genincode
February 25, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/aim-market-roundup-phoenix-copper-170020859.html
GENinCode Raises £4.1m Following Completion of WRAP Retail Offer
January 26, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-raises-4-1m-following-completion-of-wrap-retail-offer?utm_source=marketbeat.com&utm_medium=referral
TRADING UPDATES: GENinCode to raise funds via placing and subscription
January 21, 2026  |  lse.co.ukhttps://www.lse.co.uk/news/trading-updates-genincode-to-raise-funds-via-placing-and-subscription-pey94ezuzlqzggl.html
See More GENinCode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GENinCode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GENinCode and other key companies, straight to your email.

About GENinCode

GENinCode (LON:GENI) is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

View GENinCode Profile
Earnings Tools